Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis

OBJECTIVES: Systemic sclerosis (SSc) patients are at risk for a severe disease course during SARS-CoV-2 infection either due to comorbidities or immunosuppression. The availability of SARS-CoV-2 vaccines is crucial for the prevention of this hard-to-treat illness. The aim of this study is to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellicano, Chiara, Campagna, Roberta, Oliva, Alessandra, Leodori, Giorgia, Miglionico, Marzia, Colalillo, Amalia, Mezzaroma, Ivano, Mastroianni, Claudio Maria, Turriziani, Ombretta, Rosato, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132599/
https://www.ncbi.nlm.nih.gov/pubmed/35614287
http://dx.doi.org/10.1007/s10067-022-06219-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132599/
https://www.ncbi.nlm.nih.gov/pubmed/35614287
http://dx.doi.org/10.1007/s10067-022-06219-7

Ejemplares similares